journal article·2025-01-08

Dual-Targeted Drug Delivery to Myeloid Leukemia Cells via Complement- and Transferrin-Based Protein Corona

Wen Wu, Yuanyuan Li, Qihui Liu, Tao Liu, Yanan Zhao, Hui Shao, Ping Ren, Yueyang Tang, Jiayi Feng, Yihan Wang, Guodong Sun, Haiyan Liu, Yuansong Bai, Fangfang Chen

Nano Letters· Volume 25· Issue 1
Publisher page

Abstract

Although traditionally regarded as an impediment, the protein corona can facilitate the advancement of targeted drug delivery systems. This study presents an innovative approach for targeting acute myeloid leukemia (AML) using nanoparticles with agglutinated protein (NAPs). Agglutinated transferrin and C3b in NAPs selectively bind to CD71 and CD11b, receptors that are overexpressed on myeloid leukemic cells compared to nonmalignant cells. In vitro, NAPs achieved a 73.9% doxorubicin (DOX) uptake in leukemic cells, compared to 6.19% for the free drug, while significantly reducing off-target accumulation in normal cells from 42.9% to 5.76%. In vivo, the distribution of NAPs correlated to the organ infiltration pattern of leukemic cells. NAPs demonstrated antileukemic activity in both in vitro and in vivo NSG mouse models, inducing cell death via apoptosis and ferroptosis. In conclusion, NAP-mediated targeted drug delivery represents a promising therapeutic strategy for AML, enhancing treatment efficacy and minimizing off-target effects.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Iron Metabolism and Disorders · Nanoparticle-Based Drug Delivery · Hemoglobinopathies and Related Disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, Key Laboratory of Pathobiology, Ministry of Education, Nanomedicine and Translational Research Center, China-Japan Union Hospital of Jilin University, Changchun 130033, P. R. China

Department of Gastrointestinal, Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun 130033, P. R. China

Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun 130033, P. R. China

Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun 130033, P. R. China

Guangdong Provincial Key Laboratory of Spine and Spinal Cord Reconstruction, The Fifth Affiliated Hospital (Heyuan Shenhe People’s Hospital), Jinan University, Heyuan 517000, P. R. China

Key Laboratory of Pathobiology Ministry of Education, Department of Anatomy, College of Basic Medical Sciences, Jilin University, Changchun 130021, P. R. China

Funding

Natural Science Foundation of Jilin Province · National Key Research and Development Program of China · Program for Jilin University Science and Technology Innovative Research Team · Jilin University · National Natural Science Foundation of China

References (27)

Show source-provided references
1. 10.1016/j.semcancer.2019.11.00210.1016/j.semcancer.2019.11.002 ↗
2. 10.1038/nnano.2012.23710.1038/nnano.2012.237 ↗
3. 10.1038/s41565-018-0171-610.1038/s41565-018-0171-6 ↗
4. 10.1002/adma.20220727110.1002/adma.202207271 ↗
5. 10.1021/acsnano.8b0180610.1021/acsnano.8b01806 ↗
6. 10.1038/nnano.2015.33010.1038/nnano.2015.330 ↗
7. 10.1016/j.jconrel.2022.03.05810.1016/j.jconrel.2022.03.058 ↗
8. 10.1016/j.jaci.2017.08.04910.1016/j.jaci.2017.08.049 ↗
9. 10.1021/acsnano.1c0850810.1021/acsnano.1c08508 ↗
10. 10.1038/s41565-021-00997-y10.1038/s41565-021-00997-y ↗
11. 10.1016/j.addr.2022.11463510.1016/j.addr.2022.114635 ↗
12. 10.1016/j.addr.2022.11435610.1016/j.addr.2022.114356 ↗
13. 10.1002/adma.20180574010.1002/adma.201805740 ↗
14. 10.1038/s41565-021-00856-w10.1038/s41565-021-00856-w ↗
15. 10.7150/thno.6737510.7150/thno.67375 ↗
16. 10.1016/j.jbc.2021.10025610.1016/j.jbc.2021.100256 ↗
17. 10.4049/jimmunol.200120810.4049/jimmunol.2001208 ↗
18. 10.1021/acsnano.5b0506110.1021/acsnano.5b05061 ↗
19. 10.1016/j.cell.2010.06.02810.1016/j.cell.2010.06.028 ↗
20. 10.1016/j.freeradbiomed.2018.06.03710.1016/j.freeradbiomed.2018.06.037 ↗
21. 10.1038/s41565-021-00980-710.1038/s41565-021-00980-7 ↗
22. 10.1073/pnas.182102211610.1073/pnas.1821022116 ↗
23. 10.1021/acscentsci.9b0110510.1021/acscentsci.9b01105 ↗
24. 10.1186/s12951-021-01097-810.1186/s12951-021-01097-8 ↗
25. 10.1021/acs.nanolett.0c0270110.1021/acs.nanolett.0c02701 ↗
26. 10.1039/D2NR02603A10.1039/D2NR02603A ↗
27. 10.1038/s41375-021-01164-x10.1038/s41375-021-01164-x ↗